| Literature DB >> 32268831 |
Morgan B Frazer1, Joseph Bubalo2, Himanshu Patel3, Jim Siderov4, Milagros Cubilla5, Mário De Lemos6, Harbans Dhillon7, Jatinder Harchowal8, Nirachorn Kuchonthara9, Annemeri Livinalli10, Rodrigo Macedo11, Winnie Mwangi12, Hisanaga Nomura13, Shaun O'Connor14, Maggie Patterson15, Mayde Seadi Torriani16, Barbara Yim17, Alexandre Chan17, Emma Foreman8.
Abstract
Entities:
Keywords: Biologic drugs; biosimilar pharmaceuticals; clinical practice guideline; economics; international perspectives; pharmaceutical
Year: 2020 PMID: 32268831 DOI: 10.1177/1078155219893441
Source DB: PubMed Journal: J Oncol Pharm Pract ISSN: 1078-1552 Impact factor: 1.809